|1.||Karabak, V I: 2 articles (01/2000 - 01/2000)|
|2.||Lemieux, Pierre: 1 article (01/2015)|
|3.||Thibeault, Roseline: 1 article (01/2015)|
|4.||Bergeron, Luc: 1 article (01/2015)|
|5.||Grégoire, Jean-Pierre: 1 article (01/2015)|
|6.||Lando, A: 1 article (11/2014)|
|7.||Michel, F: 1 article (11/2014)|
|8.||Leone, M: 1 article (11/2014)|
|9.||Nicoleta, P: 1 article (11/2014)|
|10.||Bechis, C: 1 article (11/2014)|
05/01/1986 - "This open study shows Timentin to be a safe and effective antibiotic for the treatment of infection."
11/01/1989 - "We conclude that ticarcillin/clavulanic acid is safe and effective therapy for serious infections in hospitalized children."
05/01/1986 - "In an open study 50 patients were treated for a variety of infections with 3.2 g Timentin 6, 8- or 12-hourly for a mean period of six days. "
05/01/1986 - "An open study of Timentin for the initial treatment of serious infections."
05/01/1986 - "The antimicrobial spectrum of Timentin is valuable in the management of nosocomial and polymicrobial infection, especially intra-abdominal infections and this study confirms a good clinical efficacy. "
07/01/1989 - "Thirty-two children (ages 5.7 +/- 3.5 years) with skin and soft tissue infections received Timentin for 5.3 +/- 1.6 days with 22 of 32 cures, 10 of 32 improved, 32 of 32 bacteriologic cures and 1.4 +/- 1.3 days of fever. "
07/01/1989 - "Sixteen children (ages 6.2 +/- 3.9 years) with bone and joint infections received Timentin for 8.7 +/- 2.4 days with 11 of 16 cures, 5 of 16 improved, 11 of 11 bacteriologic cures and 3.9 +/- 3.5 days of fever. "
05/01/1986 - "In addition, 13 episodes of fever and four of septicaemia in patients with agranulocytosis were treated with Timentin plus amikacin. "
06/01/2003 - "We evaluated the efficacy of ticarcillin-clavulanic acid plus amikacin (TCA) with ceftazidime plus amikacin (CFA) as empiric therapy of fever in acute leukemia in a total of 127 episodes. "
06/01/2003 - "Ticarcillin-clavulanic acid plus amikacin versus ceftazidime plus amikacin in the empirical treatment of fever in acute leukemia: a prospective randomized trial."
09/01/1987 - "Additional studies in animals and humans are required before recommendations can be made regarding the use of ticarcillin-clavulanic acid for treatment of meningitis."
05/01/1989 - "Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis."
05/01/1989 - "The penetration into cerebrospinal fluid (CSF) and efficacy of ticarcillin-clavulanic acid, ticarcillin alone, and ceftazidime were compared in rabbits with experimentally induced Klebsiella pneumoniae meningitis. "
09/01/1987 - "Pharmacokinetics and bacteriological efficacy of ticarcillin-clavulanic acid (timentin) in experimental Escherichia coli K-1 and Haemophilus influenzae type b meningitis."
01/01/2000 - "The activity of ticarcillin/clavulanate (Timentin) was practically the same as that of imipenem against 21 strains of P.aeruginosa isolated from the blood and cerebrospinal fluid of 21 patients with sepsis and 3 patients with secondary purulent meningitis."
|4.||Urinary Tract Infections (Urinary Tract Infection)
05/01/1986 - "Timentin proved to be highly effective in the treatment of 70 urological patients suffering from complicated urinary tract infections. "
05/01/1986 - "Clinical evaluation of Timentin in complicated urinary tract infections."
11/29/1985 - "The safety and effectiveness of Timentin were evaluated in 34 adult patients with symptomatic complicated urinary tract infections, principally due to multiply-drug-resistant bacteria. "
11/29/1985 - "Timentin in the treatment of symptomatic complicated urinary tract infections in adult patients."
05/01/1986 - "The results show that Timentin is a very useful drug for the urologist who often treats complicated urinary tract infections, especially because of its low re- and super-infection rate and the absence of development of resistance."
|5.||Critical Illness (Critically Ill)
05/01/1996 - "Clearance of ticarcillin-clavulanic acid by continuous venovenous hemofiltration in three critically ill children, two with and one without concomitant extracorporeal membrane oxygenation."
10/15/2005 - "We reviewed the literature for studies involving the following antibiotics frequently used to treat critically ill adult patients receiving CRRT: vancomycin, linezolid, daptomycin, meropenem, imipenem-cilastatin, nafcillin, ampicillin-sulbactam, piperacillin-tazobactam, ticarcillin-clavulanic acid, cefazolin, cefotaxime, ceftriaxone, ceftazidime, cefepime, aztreonam, ciprofloxacin, levofloxacin, moxifloxacin, clindamycin, colistin, amikacin, gentamicin, tobramycin, fluconazole, itraconazole, voriconazole, amphotericin B (deoxycholate and lipid formulations), and acyclovir. "
|3.||Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)
|4.||ticarcillin-clavulanic acid (Timentin)
|5.||Clavulanic Acid (Potassium Clavulanate)
|1.||Extracorporeal Membrane Oxygenation (ECMO)